Literature DB >> 14550701

Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study.

Dennis Chan1, John C Janssen, Jennifer L Whitwell, Hilary C Watt, Rhian Jenkins, Chris Frost, Martin N Rossor, Nick C Fox.   

Abstract

The extent to which cerebral atrophy in Alzheimer's disease changes with time is unknown. We used multiple MRI scans to measure progression of cerebral atrophy in 12 patients with Alzheimer's disease who were followed up from a presymptomatic stage through to moderately severe dementia. Analysis with hierarchical regression models with quadratic terms in time provided evidence of increasing yearly percentage losses in brain volume. At the time when patients were judged to have mild dementia (mini-mental state examination score MMSE=23), mean yearly loss of brain volume was 2.8% (95% CI 2.3-3.3), which rose by 0.32% per year (0.15-0.50). Our findings reinforce the need for early diagnosis and therapeutic intervention in Alzheimer's disease.

Entities:  

Mesh:

Year:  2003        PMID: 14550701     DOI: 10.1016/S0140-6736(03)14469-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  66 in total

1.  The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort.

Authors:  A Caroli; G B Frisoni
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

2.  Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.

Authors:  Clifford R Jack; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Timothy G Lesnick; Val Lowe; Kejal Kantarci; Matt A Bernstein; Matthew L Senjem; Jeffrey L Gunter; Bradley F Boeve; John Q Trojanowski; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; David S Knopman
Journal:  Arch Neurol       Date:  2012-07

Review 3.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

4.  Ensemble sparse classification of Alzheimer's disease.

Authors:  Manhua Liu; Daoqiang Zhang; Dinggang Shen
Journal:  Neuroimage       Date:  2012-01-14       Impact factor: 6.556

5.  Global Cerebral Atrophy Detected by Routine Imaging: Relationship with Age, Hippocampal Atrophy, and White Matter Hyperintensities.

Authors:  Omar M Al-Janabi; Pradeep Panuganti; Erin L Abner; Ahmed A Bahrani; Ronan Murphy; Shoshana H Bardach; Allison Caban-Holt; Peter T Nelson; Brian T Gold; Charles D Smith; Donna M Wilcock; Gregory A Jicha
Journal:  J Neuroimaging       Date:  2018-01-05       Impact factor: 2.486

6.  Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

Authors:  J M Schott; C Frost; J L Whitwell; D G Macmanus; R G Boyes; M N Rossor; N C Fox
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

7.  Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia.

Authors:  Owen T Carmichael; Lewis H Kuller; Oscar L Lopez; Paul M Thompson; Rebecca A Dutton; Allen Lu; Sharon E Lee; Jessica Y Lee; Howard J Aizenstein; Carolyn C Meltzer; Yanxi Liu; Arthur W Toga; James T Becker
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Jan-Mar       Impact factor: 2.703

8.  Rates of brain atrophy over time in autopsy-proven frontotemporal dementia and Alzheimer disease.

Authors:  Jennifer L Whitwell; Clifford R Jack; V Shane Pankratz; Joseph E Parisi; David S Knopman; Bradley F Boeve; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neuroimage       Date:  2007-10-10       Impact factor: 6.556

Review 9.  Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

10.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.